Literature DB >> 16961644

Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli.

S M Soto1, A Smithson, J P Horcajada, J A Martinez, J P Mensa, J Vila.   

Abstract

Escherichia coli is the most frequent microorganism involved in urinary tract infection (UTI). Acute UTI caused by uropathogenic E. coli (UPEC) can lead to recurrent infection, which can be defined as either re-infection or relapse. E. coli strains causing relapse (n = 27) and re-infection (n = 53) were analysed. In-vitro production of biofilm, yersiniabactin and aerobactin was significantly more frequent among strains causing relapse. Biofilm assays may be helpful in selecting patients who require a therapeutic approach to eradicate persistent biofilm-forming E. coli strains and prevent subsequent relapses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16961644     DOI: 10.1111/j.1469-0691.2006.01543.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  45 in total

1.  Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.

Authors:  Matthew G Blango; Matthew A Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

2.  Escherichia coli biofilm formation and recurrences of urinary tract infections in children.

Authors:  T Tapiainen; A-M Hanni; J Salo; I Ikäheimo; M Uhari
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-02       Impact factor: 3.267

Review 3.  Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972.

Authors:  Per Klemm; Viktoria Hancock; Mark A Schembri
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

Review 4.  The iron hand of uropathogenic Escherichia coli: the role of transition metal control in virulence.

Authors:  Anne E Robinson; James R Heffernan; Jeffrey P Henderson
Journal:  Future Microbiol       Date:  2018-06-05       Impact factor: 3.165

5.  Molecular characterisation of Escherichia coli isolated from hospitalised children and adults with urinary tract infection.

Authors:  T L Vollmerhausen; M Katouli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-03       Impact factor: 3.267

6.  Impact of the RNA chaperone Hfq on the fitness and virulence potential of uropathogenic Escherichia coli.

Authors:  Richard R Kulesus; Karen Diaz-Perez; E Susan Slechta; Danelle S Eto; Matthew A Mulvey
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

7.  Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37.

Authors:  Ylva Kai-Larsen; Petra Lüthje; Milan Chromek; Verena Peters; Xiaoda Wang; Asa Holm; Lavinia Kádas; Kjell-Olof Hedlund; Jan Johansson; Matthew R Chapman; Stefan H Jacobson; Ute Römling; Birgitta Agerberth; Annelie Brauner
Journal:  PLoS Pathog       Date:  2010-07-22       Impact factor: 6.823

8.  Uropathogenic Escherichia coli isolates from pregnant women in different countries.

Authors:  Nubia L Ramos; Musa Sekikubo; Dang Thi Ngoc Dzung; Corinna Kosnopfel; Fred Kironde; Florence Mirembe; Annelie Brauner
Journal:  J Clin Microbiol       Date:  2012-08-22       Impact factor: 5.948

9.  Antimicrobial non-susceptibility of cervico-vaginal and rectal Escherichia coli isolates is associated with phylogeny and plasmid carriage.

Authors:  D W Hilbert; T E Paulish; E Mordechai; M E Adelson; S E Gygax; J P Trama
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-07-29       Impact factor: 3.267

10.  Carboxylic acid isosteres improve the activity of ring-fused 2-pyridones that inhibit pilus biogenesis in E. coli.

Authors:  Veronica Berg; Pralay Das; Erik Chorell; Mattias Hedenström; Jerome S Pinkner; Scott J Hultgren; Fredrik Almqvist
Journal:  Bioorg Med Chem Lett       Date:  2008-05-07       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.